[
  {
    "date": "2012-02-28",
    "symbol": "CNNA",
    "period": "FY",
    "entityregistrantname": "Bioflamex Corp",
    "entitycentralindexkey": 1368620,
    "documenttype": "10-K",
    "documentperiodenddate": "2012-02-29",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--02-28",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Smaller Reporting Company",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2012,
    "cashandcashequivalentsatcarryingvalue": 191,
    "assetscurrent": 191,
    "indefinitelivedintangibleassets": 1191000,
    "assets": 1191191,
    "accountspayableandaccruedliabilitiescurrent": 159589,
    "accruedliabilitiescurrent": 12385,
    "interestpayablecurrent": 7047,
    "notespayablerelatedpartiesclassifiedcurrent": 4034,
    "convertibledebtcurrent": 60500,
    "liabilitiescurrent": 243555,
    "commonstockvalue": 9300,
    "additionalpaidincapital": 1337500,
    "developmentstageenterprisedeficitaccumulatedduringdevelopmentstage": -399164,
    "stockholdersequity": -399164,
    "liabilitiesandstockholdersequity": 1191191,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 93000001,
    "generalandadministrativeexpense": 26714,
    "consultingfees": 152979,
    "sharebasedcompensation": 30000,
    "professionalfees": 48180,
    "operatingexpenses": 257872,
    "incomelossfromcontinuingoperations": -257872,
    "interestexpense": -6787,
    "interestexpenserelatedparty": -258,
    "foreigncurrencytransactiongainlossbeforetax": 337,
    "otherincomeandexpenses": -6708,
    "operatingincomeloss": -264581,
    "weightedaveragenumberofbasicdilutedsharesoutstanding": 92816184,
    "sharesoutstanding": -264581,
    "stockissuedforcash0.15shares": 333334,
    "stockissuedforcash0.15value": 49967,
    "stockissuedforservicesshares": 200000,
    "stockissuedforservicesvalue": 29980,
    "profitloss": -264581,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecrease": 30000,
    "increasedecreaseinprepaidexpense": 10000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 151247,
    "increasedecreaseinaccuredexpensesrelatedparties": 12385,
    "increasedecreaseinaccruedinterest": 7047,
    "netcashprovidedbyusedinoperatingactivities": -53902,
    "proceedsfromrelatedpartydebt": 4034,
    "proceedsfromissuanceorsaleofequity": 50000,
    "netcashprovidedbyusedinfinancingactivities": 54034,
    "cashperiodincreasedecrease": 132,
    "cash": 191,
    "stockgrantedduringperiodvaluesharebasedcompensation": 30000
  }
]